Dexcom is committed to providing healthcare professionals with the latest clinical evidence to demonstrate positive outcomes for Dexcom rt-CGM. We’ve also included available professional society guidance and criteria that can help identify patients who could benefit from Continuous Glucose Monitoring (CGM) technology, such as Dexcom G6.
Clinical Studies
Review Peer-reviewed evidence demonstrating the positive impact that CGM has on glycaemic control and variability.
Professional Society Guidelines
Professional societies continue to expand their recommendation of technology use in patient care protocols for both adult and paediatric patients with type 1 diabetes. CGM Systems are included on the long-term illness scheme and are available to people with type 1 diabetes who meet the clinical requirements. There are no set criteria for CGM use in children with type 1 diabetes but most consultants use the National Institute for Health and Care Excellence (NICE) guidelines in the UK.